Bernstein: 'We See the Most Risk Trom Tariffs to Thermo Fisher Scientific (TMO)'

Bernstein SocGen Group analyst Eve Burstein reiterated an Outperform rating and $690.00 price target on Thermo Fisher Scientific (NYSE: TMO).

The analyst commented: "We see the most risk from tariffs to TMO, and the least risk to A and WAT (with RVTY right behind them). There are many limitations to this analysis (e.g., it doesn’t take into account company ability to pass on price to customers, which should be high given that tools are quite sticky; it doesn’t take reciprocal tariffs into account; etc.), but we hope it helps to quantify relative risk among companies, and give a base case of impact from which to start.

Although this analysis makes us incrementally more bearish on TMO at these prices we think that Thermo is still a solid play in the tough environment given their best in class commercial ability and their production exposure."

For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.

Shares of Thermo Fisher Scientific closed at $427.44 yesterday.

You May Also Be Interested In

• Bumble Inc. (BMBL) PT Lowered to $3.20 at Citi
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c